<SEC-DOCUMENT>0001776985-22-000081.txt : 20221208
<SEC-HEADER>0001776985-22-000081.hdr.sgml : 20221208
<ACCEPTANCE-DATETIME>20221207173921
ACCESSION NUMBER:		0001776985-22-000081
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20221207
FILED AS OF DATE:		20221208
DATE AS OF CHANGE:		20221207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BioNTech SE
		CENTRAL INDEX KEY:			0001776985
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			2M
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39081
		FILM NUMBER:		221450983

	BUSINESS ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
		BUSINESS PHONE:		0049613190847081

	MAIL ADDRESS:	
		STREET 1:		AN DER GOLDGRUBE 12
		CITY:			MAINZ
		STATE:			2M
		ZIP:			55131
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-ksharebbsecondtranch.htm
<DESCRIPTION>6-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i581d73682efc4830ac598aaf09fda8a4_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">UNITED STATES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">FORM 6-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a&#8209;16 OR 15d&#8209;16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNDER THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FOR THE MONTH OF DECEMBER 2022</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">COMMISSION FILE NUMBER 001-39081 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%">BioNTech SE<br></font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Translation of registrant&#8217;s name into English)</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">An der Goldgrube 12</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">D-55131 Mainz</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Germany</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">+49 6131-9084-0<br></font><font style="color:#333333;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20&#8209;F or Form 40&#8209;F&#58; Form 20&#8209;F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9746;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Form 40&#8209;F </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6&#8209;K in paper as permitted by Regulation S&#8209;T Rule 101(b)(1)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is submitting the Form 6&#8209;K in paper as permitted by Regulation S&#8209;T Rule 101(b)(7)&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9744;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="text-align:center"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DOCUMENTS INCLUDED AS PART OF THIS FORM 6-K</font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">On December 7, 2022, the share buyback program announced by BioNTech SE (&#8220;BioNTech&#8221;) on March 31, 2022 will be continued in a second tranche. BioNTech expects to repurchase up to USD 500 million of its American Depositary Shares (&#8220;ADSs&#8221;) on the U.S. Nasdaq stock exchange in the period from December 7, 2022 until March 17,2023 (the &#8220;Share Buyback&#34;). The announcement is attached hereto as Exhibit 99.1.</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURE</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.560%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:125%">BioNTech SE</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; Dr. Sierk Poetting</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Name&#58; Dr. Sierk Poetting</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Title&#58;   Chief Operating Officer</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; December 7, 2022 </font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXHIBIT INDEX </font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.895%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:87.905%"></td><td style="width:0.1%"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Exhibit</font></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%;text-decoration:underline">Description of Exhibit</font></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline"><a href="ex991sharebbsecondtranche0.htm" style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Disclosure of share buyback program pursuant to Art. 5(1) lit. a) of Regulation (EU) No. 596&#47;2014 of the European Parliament and the Council of April 16, 2014 and Art. 2(1) of Delegated Regulation (EU) 2016&#47;1052 of the European Commission of March 8, 2016</a></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="padding-left:0.35pt;padding-right:0.35pt;text-align:justify"><font><br></font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991sharebbsecondtranche0.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i4c6bb89a69f34f11828fa4ac01ea976b_1"></div><div style="min-height:120.83pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div><div><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.560%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.240%"></td><td style="width:0.1%"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:2.75pt;padding-right:2.75pt"><img alt="image_0.jpg" src="image_0.jpg" style="height:26px;margin-bottom:5pt;vertical-align:text-bottom;width:240px"></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:107%">Disclosure of share buyback program pursuant to Art. 5(1) lit. a) of Regulation (EU) No. 596&#47;2014 of the European Parliament and the Council of April 16, 2014 and Art. 2(1) of Delegated Regulation (EU) 2016&#47;1052 of the European Commission of March 8, 2016</font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:107%">Mainz, Germany, December 7, 2022 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">&#8212; The share buyback program announced by BioNTech SE (&#8220;BioNTech&#8221;) on March 31, 2022 will be continued in a second tranche. BioNTech expects to repurchase up to USD 500 million of its American Depositary Shares (&#8220;ADSs&#8221;) on the U.S. Nasdaq stock exchange  in the period from December 7, 2022 until March 17, 2023 (the &#8220;Share Buyback&#8221;). BioNTech expects to use all or a portion of the repurchased ADSs to satisfy upcoming settlement obligations under BioNTech&#8217;s share-based payment arrangements. </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">The Share Buyback will be lead-managed by a credit institution mandated by BioNTech, which will make trading decisions concerning the timing of the purchases of BioNTech&#8217;s shares independently of BioNTech within the meaning of Art. 4(2) lit. b) of Delegated Regulation (EU) 2016&#47;1052 and BioNTech will not exercise any influence over such decisions. BioNTech&#8217;s right to terminate the credit institution&#8217;s mandate remains unaffected and the Share Buyback may be stopped and continued at any time in accordance with relevant legal requirements.</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">For the Share Buyback to be covered by the safe harbor regulations for share buybacks and applicable provisions, the credit institution shall comply with all applicable regulatory provisions, in particular, the conditions for trading in Art. 3 of Delegated Regulation (EU) 2016&#47;1052. Art. 3 requires, inter alia, that shares may not be purchased at a price higher than the higher of the price of the last independent trade and the highest current independent purchase bid on the trading venue where the purchase is carried out. In addition, no more than 25% of the average daily volume of the shares at the stock exchange on which the purchase is carried out may be purchased. The average daily trading volume of shares is based on the average daily volume traded in the 20 trading days preceding the date of the relevant purchase. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:107%">Transactions made under the Share Buyback will be duly disclosed pursuant to the requirements of Art. 2 para. 3 of Delegated Regulation (EU) No. 2016&#47;1052 no later than by the end of the seventh trading day following the date of the execution of the transaction in a detailed form and in an aggregated form. BioNTech will publish the disclosed transactions on its website at https&#58;&#47;&#47;investors.biontech.de&#47;share-repurchase and will keep that information publicly accessible for a period of at least five years from the date of public disclosure.</font></div><div style="height:59.84pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">1</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<TEXT>
begin 644 image_0.jpg
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M"&-NC9069CS&A5<="%$(W3^ ^NRY)57H_@DI-XN-]2R_+TWWGQ/&P*3,\ &
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MGSVWI K=/R'D?[)VN!.?JWRB^W>'A]\)>5.R.5U/AVT12DMU/-OMG<?;!1!
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MSR9L%F98;"U$AN;]O_[Q\-B)-R4 ?!G=/P"@*'SF\$N9WUY=.]QIG%0,10$
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M .,B^!D8C^>T/MW_6_SZQP]VR;VG=;42KR=DT/WGA.X? *!/\%<.G0ZR  "
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M=/^9^=CY9W4\:__0KA/VTH?'3KRJDT3WGQ.Z?P" %[)C+EYX / :.E/?=/]
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MZ?ZAI]L[SZ_^;[86'AX[\:H.0_>?$[I_ (!37A[.#MD_:\9+#Z \.E/?=/]
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M P!<VSC:M8,C\5#_ V72F?JF^P<B]C!)%;I_0)?4P,-1C:US ^1HH[V&KQ_
M&V1N<SFS-YCAB,?B?R:[$U>?[A]^M&_W[)[C/:VKE7@]GZ'[SPG=/P# -8\O
M/,Q0_P-%TIGZIOL'(O8P216Z?T"7SK$YXZH-TKD!<K317J.Z/+7KZ"+[9\UX
M98 )<UK\A[0[=_'*.&=KH22A^\=KW'S\J3J>M?N/Z[2N5AX>._&J?D+WGQ.Z
M?P" =U*S<*\/]3]0&IVI;[I_(&(/DU2A^P=TV6,D81S5V#HW0(XVVBO-;Z_:
MU701ZG],D]0OMKPI:X<[\<KX9VNA)*'[QRMU>^?YU?_-UL)GZW^Z_YS0_0,
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M'@D/PC< "A3^XAM'N\JGY?H):U?(;SW:6BA)Z/XQ":VK%;NSD1%"]U\?W3\
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M2$6R?ZB'FS]_D5/ N&3_^9#]!X,V$2+V2L?##B=78Y[;B)DZBK'MM+X=#1I
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M.ZUO1X,&4 8Y3;3\+_N_N;];OF41\0?D\U-3++-2=;DQ0 L[LZ!U_KCH_HD
MI?@R^\V"\\5U]R\#@)>7I^>9G"_E37]&]R^#[\3(I4S^_<]=]X^#[X<V$2+V
M2L<#%)$W)&*FCCI7=II^C@8-H QRFFB9IN>_0L%"C+00/OD     245.1*Y"
"8((!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
